The Jayanta Chaudhuri Lab
Laboratory of Molecular and Cellular Immunology
Recombination, genomic integrity, and heterogeneity in B cells
William T. Yewdell, Youngjun Kim, Priyanka Chowdhury, Colleen M. Lau1, Ryan M. Smolkin, Kalina T. Belcheva, Keith C. Fernandez, Montserrat Cols, Wei-Feng Yen, Bharat Vaidyanathan, Davide Angeletti, Adrian B. McDermott, Jonathan W. Yewdell, Joseph C. Sun, Jayanta Chaudhuri. (2020) A hyper-IgM syndrome mutation in AID disrupts G-quadruplex binding and chromatin localization. Immunity (In Press).
Angeletti, D., I. Kosik, J. J. S. Santos, W. T. Yewdell, C. M. Boudreau, V. V. A. Mallajosyula, M. C. Mankowski, M. Chambers, M. Prabhakaran, H. D. Hickman, A. B. McDermott, G. Alter, J. Chaudhuri, and J. W. Yewdell. (2019) Outflanking immunodominance to target subdominant broadly neutralizing epitopes. Proc Natl Acad Sci USA 116: 13474-13479. PMCID: PMC6986270
Pucella JN, Cols M, Yen W-F, Xu S and Chaudhuri J. The B cell activation induced miR-183 cluster plays a minimal role in canonical primary humoral responses. (2019) J. Immunology; 202(5): 1383-1396. PMCID: PMC6986270
Nicolas L, Cols M, Smolkin R, Fernandez KC, Yewdell WT, Yen W-F, Zha S, Vuong B and Chaudhuri J. ATM influences germinal center integrity.(2019) Cutting Edge: Journal of Immunology; 202 (11): 3137-3142. PMCID: PMC6529280
Yen W-F, Sharma R, Cols M, Lau CM, Chaudhry A, Chowdhury P, Yewdell WT, Vaidyanathan B, Sun A, Coffre M, Pucella JN, Chen C-C, Jasin M, Sun JC, Rudensky AY, Koralob SB and Chaudhuri J. (2019). Distinct requirements of CHD4 during B cell development and antibody response. Cell Reports 27(5):1472-1486. PMCID: PMC6527137
Jayanta Chaudhuri, PhD
- Immunologist Jayanta Chaudhuri studies the mechanisms of immunoglobulin gene diversification.
- PhD, Albert Einstein College of Medicine
- [email protected]
- Email Address
- Office Phone
- Office Phone
- Office Fax
- Cornell University
To learn more about available postdoctoral opportunities, please visit our Career Center
To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs
Get in Touch
Lab Head Email
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Jayanta Chaudhuri discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].